Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Esperion Theraptc (NQ: ESPR ) 2.340 +0.120 (+5.41%) Streaming Delayed Price Updated: 4:00 PM EDT, Jul 1, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 10,041,540 Open 2.230 Bid (Size) 2.350 (19) Ask (Size) 2.360 (36) Prev. Close 2.220 Today's Range 2.220 - 2.500 52wk Range 0.7000 - 3.400 Shares Outstanding 28,277,493 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Esperion Announces Monetization of European Royalties and Concurrent Payoff and Termination of Existing Revenue Interest Facility June 28, 2024 From Esperion Therapeutics, Inc. Via GlobeNewswire Wall Street's Top 10 Stock Calls This Week - Saturday, June 22 June 22, 2024 What has Wall Street been buzzing about this week? Here are the top 5 buy calls and the top 5 sell calls made by Wall Street's best analysts during the trading week of June 17-21, 2024. Via Talk Markets Performance YTD -19.86% -19.86% 1 Month +4.46% +4.46% 3 Month -16.13% -16.13% 6 Month -19.86% -19.86% 1 Year +64.79% +64.79% More News Read More Workday To Rally Over 52%? Here Are 10 Top Analyst Forecasts For Thursday June 20, 2024 Via Benzinga Stocks to Buy: 3 Biotech Bargains Delivering Breakthroughs on a Budget June 13, 2024 Via InvestorPlace Why Jabil Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session June 20, 2024 Via Benzinga 3 Penny Stocks to Buy if You Want to Spend Less and Earn More June 11, 2024 Via InvestorPlace Argan Reports Strong Earnings, Joins Geron, Planet Labs PBC And Other Big Stocks Moving Higher On Friday June 07, 2024 Via Benzinga Why Skye Bioscience Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Monday's Mid-Day Session June 10, 2024 Via Benzinga Esperion to Participate in Upcoming June Investor Conferences May 23, 2024 From Esperion Therapeutics, Inc. Via GlobeNewswire First-In-Class Cholesterol-Lowering Treatment NILEMDO® (NEXLETOL® in the U.S.) and Its Combination with Ezetimibe, NUSTENDI® (NEXLIZET® in the U.S.), Approved In Europe To Treat Hypercholesterolemia and Significantly Reduce Cardiovascular Risk May 22, 2024 From Esperion Therapeutics, Inc. Via GlobeNewswire Esperion Therapeutics/Otsuka Partnered Cholesterol Drug Shows Effective In Japan Study May 20, 2024 Via Benzinga Bempedoic Acid Met Primary Endpoint of Phase 3 Trial in Japan for the Treatment for Hypercholesterolemia May 20, 2024 From Esperion Therapeutics, Inc. Via GlobeNewswire Esperion Receives Five Year Patent Extension for Bempedoic Acid, Contained in NEXLETOL® and NEXLIZET® May 14, 2024 From Esperion Therapeutics, Inc. Via GlobeNewswire Esperion Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) May 10, 2024 From Esperion Therapeutics, Inc. Via GlobeNewswire Investor Spotlight: Companies Poised for Growth Amid Recent Developments: VTAK, ESPR, FGEN, GSUN, INBS May 08, 2024 Via AB Newswire ESPR Stock Earnings: Esperion Therapeutics Beats EPS, Beats Revenue for Q1 2024 May 07, 2024 Via InvestorPlace Heart Disease Drugmaker Esperion Therapeutics Reports Highest Revenue Yet, Stock Soars May 07, 2024 Via Benzinga Exposures Product Safety Why Is AgriFORCE Growing (AGRI) Stock Down 31% Today? May 07, 2024 Via InvestorPlace Why Is GreenPower Motor (GP) Stock Down 36% Today? May 07, 2024 Via InvestorPlace Why Is Esperion Therapeutics (ESPR) Stock Up 13% Today? May 07, 2024 Via InvestorPlace 12 Health Care Stocks Moving In Tuesday's Pre-Market Session May 07, 2024 Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday May 07, 2024 Via InvestorPlace Esperion Reports First Quarter 2024 Financial Results May 07, 2024 From Esperion Therapeutics, Inc. Via GlobeNewswire Esperion to Participate in Upcoming May Investor Conferences April 29, 2024 From Esperion Therapeutics, Inc. Via GlobeNewswire Esperion to Report First Quarter 2024 Financial Results on May 7 April 23, 2024 From Esperion Therapeutics, Inc. Via GlobeNewswire Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
